MX2015012075A - Forma de dosis farmaceutica de capsula de gelatina blanda. - Google Patents

Forma de dosis farmaceutica de capsula de gelatina blanda.

Info

Publication number
MX2015012075A
MX2015012075A MX2015012075A MX2015012075A MX2015012075A MX 2015012075 A MX2015012075 A MX 2015012075A MX 2015012075 A MX2015012075 A MX 2015012075A MX 2015012075 A MX2015012075 A MX 2015012075A MX 2015012075 A MX2015012075 A MX 2015012075A
Authority
MX
Mexico
Prior art keywords
dosage form
gelatin capsule
soft gelatin
capsule dosage
pharmaceutical soft
Prior art date
Application number
MX2015012075A
Other languages
English (en)
Inventor
Brendan Muldoon
Stephen Mccullagh
Original Assignee
Warner Chilcott Co Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Chilcott Co Llc filed Critical Warner Chilcott Co Llc
Publication of MX2015012075A publication Critical patent/MX2015012075A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A61K9/4825—Proteins, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Una forma de dosis farmacéutica de cápsula de gelatina blanda que incluye (a) una cubierta que incluye gelatina y un plastificante; y (b) un relleno que incluye al menos un ingrediente activo, polietilenglicol, ácido poliacrílico, un agente neutralizador, y agua. El agente neutralizador es una amina primaria o una amina secundaria, y está presente en una cantidad necesaria para proporcionar una forma de dosis farmacéutica de cápsula de gelatina blanda que tiene una disolución estable después del almacenamiento.
MX2015012075A 2013-03-15 2014-03-14 Forma de dosis farmaceutica de capsula de gelatina blanda. MX2015012075A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361794813P 2013-03-15 2013-03-15
PCT/US2014/027093 WO2014152226A1 (en) 2013-03-15 2014-03-14 Pharmaceutical soft gelatin capsule dosage form

Publications (1)

Publication Number Publication Date
MX2015012075A true MX2015012075A (es) 2016-05-10

Family

ID=50391548

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2015012075A MX2015012075A (es) 2013-03-15 2014-03-14 Forma de dosis farmaceutica de capsula de gelatina blanda.

Country Status (11)

Country Link
US (1) US20140271837A1 (es)
EP (1) EP2968183B1 (es)
JP (1) JP6335269B2 (es)
CN (1) CN105392476B (es)
AU (1) AU2014240039B2 (es)
CA (1) CA2906619C (es)
ES (1) ES2681982T3 (es)
HK (1) HK1220113A1 (es)
IL (1) IL242438B (es)
MX (1) MX2015012075A (es)
WO (1) WO2014152226A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10673197B2 (en) 2016-09-29 2020-06-02 Nlight, Inc. Fiber-based optical modulator
US10673198B2 (en) 2016-09-29 2020-06-02 Nlight, Inc. Fiber-coupled laser with time varying beam characteristics
US10673199B2 (en) 2016-09-29 2020-06-02 Nlight, Inc. Fiber-based saturable absorber

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK242083D0 (da) * 1983-05-27 1983-05-27 Hansens Chr Bio Syst Vaginalkapsler
US5102666A (en) * 1990-09-11 1992-04-07 Oramed, Inc. Calcium polycarbophil controlled release composition and method
IT1275816B1 (it) * 1995-10-27 1997-10-17 Montefarmaco Spa Composizioni farmaceutiche solide per uso vaginale
AU1925697A (en) 1996-03-12 1997-10-01 Novartis Ag Filled gelatin capsules having a reduced degree of cross-linking
US20040131670A1 (en) * 2001-04-17 2004-07-08 Ping Gao Pellicle-resistant gelatin capsule
MXPA06007852A (es) 2004-01-15 2007-01-31 Warner Chilcott Co Inc Profarmacos di-esteroidales de estradiol.
EP1709061A1 (en) 2004-01-15 2006-10-11 Warner Chilcott Company Inc. Di-steroidal prodrugs of ethinyl estradiol
US10016442B2 (en) 2005-06-16 2018-07-10 Allergan Pharmaceuticals International Limited Estrogen compositions for vaginal administration
US20070015741A1 (en) 2005-07-12 2007-01-18 James Keown Novel prodrugs of estradiol
EP2390260B1 (en) 2005-07-12 2014-09-17 Warner Chilcott Company, LLC Ester derivative of ethinyl estradiol
CN101360485B (zh) * 2005-10-26 2013-04-17 班纳制药公司 作为胶囊填充物的基于亲水性载体的双重控释基质系统
US20070104778A1 (en) * 2005-11-07 2007-05-10 Hongxia Zeng Controlled-release emulsion compositions
EP2011496A1 (en) * 2007-07-03 2009-01-07 Indena S.P.A. Combinations of vasoactive substances with estrogens and their use in the treatment of female sexual dysfunctions

Also Published As

Publication number Publication date
IL242438B (en) 2020-01-30
CA2906619C (en) 2021-11-16
CN105392476B (zh) 2018-11-02
US20140271837A1 (en) 2014-09-18
EP2968183B1 (en) 2018-05-09
CA2906619A1 (en) 2014-09-25
CN105392476A (zh) 2016-03-09
ES2681982T3 (es) 2018-09-17
JP6335269B2 (ja) 2018-05-30
HK1220113A1 (zh) 2017-04-28
JP2016513680A (ja) 2016-05-16
AU2014240039B2 (en) 2019-01-24
WO2014152226A1 (en) 2014-09-25
AU2014240039A1 (en) 2015-10-15
EP2968183A1 (en) 2016-01-20

Similar Documents

Publication Publication Date Title
DOP2015000051A (es) Formulaciones acuosas estables de adalimumab
EA201691193A1 (ru) Система доставки лекарственных средств
PE20151301A1 (es) Formulaciones farmaceuticas resistentes a la manipulacion indebida
PH12016500793A1 (en) Turmeric extract containing soft pastilles
MX2019004554A (es) Forma de dosis farmaceutica de capsula de gelatina blanda con goma guar modificada.
CL2017003437A1 (es) Formulación solida oral que contiene irinotecán y método de preparación de la misma
TN2012000507A1 (en) Enteric tablet
EA201690679A1 (ru) Стабильная фармацевтическая композиция, содержащая амлодипин и валсартан
EA201400737A1 (ru) Система доставки на основе множества пеллет с немедленным высвобождением активного вещества
MX2015012075A (es) Forma de dosis farmaceutica de capsula de gelatina blanda.
PH12014502856B1 (en) Solid pharmaceutical preparation containing levothyroxine
EA201501164A1 (ru) Твердая фармацевтическая лекарственная форма
SI3060203T1 (en) A effervescent tablet containing a high level of aspirin
MX2014015253A (es) Forma de dosificacion efervescente.
EA201591568A1 (ru) Пероральная таблетированная фармацевтическая композиция двойного применения на основе сульфатных солей и способы ее применения
GEP201706743B (en) Oral formulation for the treatment of cardiovascular diseases
MX2015009077A (es) Composicion estable que contiene fingolimod.
MX2015006356A (es) Formulacion de capsula de acido 5-aminosalicilico.
UY35324A (es) Composiciones farmacéuticas que contienen dexketoprofeno y tramadol
PH12014502170B1 (en) Drug composition and soft capsule drug sealing the drug composition
GEP201606594B (en) Pharmaceutical composition of sedative and spasmolytic action in soft gelatin capsules (variations)
PH12020550597A1 (en) Formulation having improved hygroscopic property and dissolution rate comprising telmisartan or its pharmaceutically acceptable salt
UA79245U (ru) Лечебный гель для глаз "таугель"
WO2013144976A3 (en) Chewable soft gelatin capsule dosage form of mucolytic agents
IN2013MU02015A (es)

Legal Events

Date Code Title Description
FG Grant or registration
PD Change of proprietorship

Owner name: ALLERGAN THERAPEUTICS LLC